The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study
- PMID: 7002129
- DOI: 10.1001/archotol.1980.00790360050013
The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study
Abstract
Double-blind studies were conducted for the treatment of idiopathic sudden hearing loss (ISHL) with oral steroids. The condition was defined as not less than a 30-dB loss over three contiguous frequencies in three days or less. Follow-up audiograms were obtained four weeks and three months later. Specific audiologic guidelines for the assessment of hearing recovery were used to ensure objectivity. Steroids had a statistically significant effect on the recovery of hearing in patients with moderate hearing losses. The nature of the hearing loss and its susceptibility to improvement with steroid therapy lend support to the hypothesis that viral cochlitis is the primary cause of ISHL.
Similar articles
-
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15. Laryngoscope. 2007. PMID: 17202923 Review.
-
Steroid use in idiopathic sudden sensorineural hearing loss.Laryngoscope. 1984 May;94(5 Pt 1):664-6. Laryngoscope. 1984. PMID: 6717224
-
Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.Laryngoscope. 2009 Feb;119(2):359-69. doi: 10.1002/lary.20074. Laryngoscope. 2009. PMID: 19172627 Clinical Trial.
-
Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.Otol Neurotol. 2011 Jul;32(5):774-9. doi: 10.1097/MAO.0b013e31821fbdd1. Otol Neurotol. 2011. PMID: 21646929 Clinical Trial.
-
Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexamethasone.Curr Opin Otolaryngol Head Neck Surg. 2016 Oct;24(5):407-12. doi: 10.1097/MOO.0000000000000288. Curr Opin Otolaryngol Head Neck Surg. 2016. PMID: 27379547 Review.
Cited by
-
Idiopathic Sudden Sensorineural Hearing Loss, But Not Compatible With the Classical Definition.Cureus. 2023 Oct 22;15(10):e47472. doi: 10.7759/cureus.47472. eCollection 2023 Oct. Cureus. 2023. PMID: 38022324 Free PMC article.
-
Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss.Adv Biomed Res. 2016 Jun 20;5:111. doi: 10.4103/2277-9175.184277. eCollection 2016. Adv Biomed Res. 2016. PMID: 27403406 Free PMC article.
-
Comparison of Different Treatment Methods for Idiopathic Sudden Sensorineural Hearing Loss.Turk Arch Otorhinolaryngol. 2018 Dec;56(4):226-232. doi: 10.5152/tao.2017.2337. Epub 2018 Dec 21. Turk Arch Otorhinolaryngol. 2018. PMID: 30701119 Free PMC article.
-
The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss.Eur Arch Otorhinolaryngol. 2011 Jun;268(6):833-9. doi: 10.1007/s00405-010-1476-8. Epub 2011 Jan 8. Eur Arch Otorhinolaryngol. 2011. PMID: 21221620 Clinical Trial.
-
Analysis of 101 patients with severe to profound sudden unilateral hearing loss treated with explorative tympanotomy and sealing of the round window membrane.Eur Arch Otorhinolaryngol. 2014 Aug;271(8):2145-52. doi: 10.1007/s00405-013-2703-x. Epub 2013 Sep 22. Eur Arch Otorhinolaryngol. 2014. PMID: 24057099
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous